Aug 18, 2017 - BMO Capital Markets issues rating change for IONS
Aug 22, 2017 - Microsoft is a legendary wealth builder. These three stocks are also poised to create plenty of millionaires in the future.
Aug 08, 2017 - Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2017 Earnings Conference Call August 08, 2017 11:30 AM ET Executives Stanley Crooke - Founder, Executive Chairman, CEO and President Wade Walke - VP of Cor
Aug 08, 2017 - Ionis Pharmaceuticals' (IONS) reported loss of 9 cents including stock based compensation was wider than expectation. However, sales beat estimates.
Aug 11, 2017 - A solid second quarter from the biotech, with growing royalties on Spinraza and two more drugs to be reviewed by regulators, and it regained full rights to two drugs after its partner declined to license them.
Oct 03, 2017 - Investors are unimpressed with data -- so far -- for the biotech's spinal muscular atrophy drug RG7916.
Oct 05, 2017 - Positive results from an important phase 3 clinical trial fueled optimism about the biotech.
Oct 24, 2017 - Investors think it's awfully early for sales of this company's first blockbuster to stagnate.
Nov 10, 2017 - A confusing quarter and pipeline uncertainty have investors scratching their heads over what to do with this biotech stock.
Nov 11, 2017 - Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2017 Results Earnings Conference Call November 07, 2017 11:30 AM ET Executives Dr. Stan Crooke - Ionis' Chairman and CEO Lynne Parshall - COO Sarah Boyce -